Puig Brands/€PUIG
1D1W1MYTD1Y5YMAX
Capital at risk
About Puig Brands
Puig Brands, S.A., traded under the ticker PUIG, is a prominent company in the beauty and fashion industry, known for its high-end products encompassing fragrances, skincare, and apparel. Founded in 1914, the company originally started in Barcelona, Spain, and has since grown into a formidable global player with a significant presence in the luxury market. Puig continues to expand its portfolio, offering a wide array of beauty and fashion products that cater to the prestigious marketplace.
- Ticker
- €PUIG
- Sector
- Consumer Essentials
- Primary listing
- BME
- Employees
- 12,079
- Headquarters
- Barcelona, Spain
- Website
- www.puig.com
Puig Brands Metrics
BasicAdvanced
€9.5B
16.33
€1.03
0.37
€0.34
2.03%
Price and volume
Market cap
€9.5B
Beta
0.37
52-week high
€18.87
52-week low
€13.20
Average daily volume
511K
Dividend rate
€0.34
Financial strength
Current ratio
1.096
Quick ratio
0.595
Long term debt to equity
0.238
Total debt to equity
0.445
Dividend payout ratio (TTM)
45.42%
Interest coverage (TTM)
13.76%
Profitability
EBITDA (TTM)
975.297
Gross margin (TTM)
74.98%
Net profit margin (TTM)
11.41%
Operating margin (TTM)
16.56%
Effective tax rate (TTM)
27.06%
Revenue per employee (TTM)
€420,000
Management effectiveness
Return on assets (TTM)
6.54%
Return on equity (TTM)
15.61%
Valuation
Price to earnings (TTM)
16.327
Price to revenue (TTM)
1.863
Price to book
2.36
Price to tangible book (TTM)
-16.01
Price to free cash flow (TTM)
16.375
Free cash flow yield (TTM)
6.11%
Free cash flow per share (TTM)
1.029
Dividend yield (TTM)
2.03%
Forward dividend yield
2.03%
Growth
Revenue change (TTM)
3.63%
Earnings per share change (TTM)
-10.79%
What the Analysts think about Puig Brands
Analyst ratings (Buy, Hold, Sell) for Puig Brands stock.
Analyst projections of the future price of Puig Brands stock.
Bulls say / Bears say
Puig delivered 4.4% like-for-like revenue growth in the first half of 2026, with every segment and region growing. It also gained market share and reaffirmed its full-year target to outperform the premium beauty market. (Puig Brands)
Make-up is providing a useful counterweight to the fragrance cycle: first-half sales rose 9.1% like-for-like to €359 million, led by Charlotte Tilbury, which gained share in premium make-up. Uriage also delivered double-digit growth in key markets, giving Puig a second growth route in dermocosmetics. (WWD)
Asia-Pacific sales rose 20.9% like-for-like in the first half, while Byredo and Dries Van Noten continued to grow at double-digit rates. Puig is also expanding its fashion retail footprint and has a pipeline of brand launches, which could extend growth beyond its established fragrance franchises. (Moodie Davitt Report, WWD)
Growth slowed sharply in the first quarter as fragrance demand moderated, and fragrances and fashion account for roughly three-quarters of sales. Travel retail represents about a tenth of revenue, leaving Puig exposed to weaker international travel, airport spending and geopolitical disruption. (Reuters)
The first-half reported net profit fell 4.4% despite higher revenue, while gross margin slipped to 75.5% from 75.8%. Stable adjusted EBITDA margin guidance suggests that higher distribution and brand-investment costs may limit near-term operating leverage. (WWD, FashionNetwork USA)
Puig paid €260 million to raise its Charlotte Tilbury stake to 85%, while net debt reached €1.589 billion, or 1.5 times adjusted EBITDA, at the half-year. Further payments towards full ownership could constrain cash available for dividends, innovation or other acquisitions if trading weakens. (MarketScreener Australia, Moodie Davitt Report)
Data summarised monthly by Lightyear AI. Last updated on 15 Sept 2026.
Puig Brands Financial Performance
Revenues and expenses
Puig Brands Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Puig Brands
AllEURGBP
Fund name | Fund size | €PUIG weighting |
|---|---|---|
iShares STOXX Europe 600 Personal & Household Goods€EXH7 | €184M | 0.29% |
Xtrackers Spain€XESD | €269M | 0.28% |
iShares EURO STOXX€SXXEEX | €2.9B | 0.03% |
Amundi STOXX Europe 600£MEUD | £6.6B | 0.02% |
Amundi STOXX Europe 600€MEUD | €7.6B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.